Insider trade

Officer sold ~$146K of COLL shares in the open market

Traded Mar 3, 2026 · Filed Mar 5, 2026

Why it stands out

Collegium Pharmaceutical's & Chief Commercial Officer sold $146K of Collegium Pharmaceutical shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Officer$100K–$500KPre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$145,880

Shares × reported transaction price

Timing vs results

5 days after results of Feb 26, 2026, 65 days before results of May 7, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	−7.5%	−1.5%	−6.0%
30 days	−12.6%	−2.0%	−10.6%
90 days	−12.3%	+12.6%	−24.9%
180 days	−34.8%	+13.8%	−48.6%

Past results only. Not a forecast.

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2025.
The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.84 to $41.35, inclusive.

6mo ago

Routine share withholding; mechanical by default.

Scheduled in advance7mo ago

Scheduled in advance7mo ago